{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T15:10:14Z","timestamp":1783350614225,"version":"3.54.6"},"reference-count":66,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US, Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001009","name":"Bristol-Myers Squibb Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bestpracticeobgyn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.bpobgyn.2014.07.020","type":"journal-article","created":{"date-parts":[[2014,8,7]],"date-time":"2014-08-07T18:00:30Z","timestamp":1407434430000},"page":"1174-1187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Immunosuppressive drugs and fetal outcome"],"prefix":"10.1016","volume":"28","author":[{"given":"Lisa A.","family":"Coscia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serban","family":"Constantinescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent T.","family":"Armenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2014.07.020_bib1","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM196308152690704","article-title":"Successful pregnancies after human renal transplantation","volume":"269","author":"Murray","year":"1963","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.bpobgyn.2014.07.020_bib2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0950-3552(05)80333-5","article-title":"Pregnancy in renal allograft recipients: problems, prognosis and practicalities","volume":"8","author":"Davison","year":"1994","journal-title":"Bailliere's Clin Obstet Gynaecol"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib3","series-title":"2013 Annual report: gift of life institute","author":"National Transplantation Pregnancy Registry (NTPR)","year":"2014"},{"issue":"12","key":"10.1016\/j.bpobgyn.2014.07.020_bib4","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1111\/ajt.12452","article-title":"Pregnancy outcomes for kidney transplant recipients","volume":"13","author":"Wyld","year":"2013","journal-title":"Am J Transplant"},{"issue":"10","key":"10.1016\/j.bpobgyn.2014.07.020_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/01.tp.0000263357.44975.d0","article-title":"Pregnancy after organ transplantation: a report from the UK transplant pregnancy registry","volume":"83","author":"Sibanda","year":"2007","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.bpobgyn.2014.07.020_bib6","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1471-0528.2005.00607.x","article-title":"Pregnancy outcome after maternal organ transplantation in Sweden","volume":"112","author":"K\u00e4ll\u00e9n","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00007890-199603150-00009","article-title":"Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection","volume":"61","author":"The Mycophenolate Mofetil Renal Refractory Rejection Study Group","year":"1996","journal-title":"Transplantation"},{"issue":"7","key":"10.1016\/j.bpobgyn.2014.07.020_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ajhp\/57.5.437","article-title":"Sirolimus: a new agent for the prevention of renal allograft rejection","volume":"57","author":"Vasquez","year":"2000","journal-title":"Am J Health Syst Pharm"},{"issue":"Suppl. 1","key":"10.1016\/j.bpobgyn.2014.07.020_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/ndt\/16.suppl_1.121","article-title":"Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation","volume":"16","author":"Morales","year":"2001","journal-title":"Nephrol Dialy Trans"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib10","unstructured":"SRTR Annual Report-Kidney [Internet]. [cited 2014 Feb 24]. Available from http:\/\/srtr.transplant.hrsa.gov\/annual_reports\/2011\/default.aspx. [accessed 24.02.14]."},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib11","series-title":"Food and Drug labeling [Internet]","author":"Department of Health and Human Services","year":"2013"},{"issue":"3","key":"10.1016\/j.bpobgyn.2014.07.020_bib12","doi-asserted-by":"crossref","first-page":"e796","DOI":"10.1542\/peds.2013-1985","article-title":"Committee on Drugs, The transfer of drugs and therapeutics into human breast milk: an update on selected topics","volume":"132","author":"Sachs","year":"2013","journal-title":"Pediatrics [Internet]"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib13","series-title":"Georgia, 1978\u20142005 [Internet]","author":"Update on Overall Prevalence of Major Birth Defects \u2013 Atlanta","year":"2008"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib14","series-title":"Handbook of teratology","first-page":"47","article-title":"Current status of teratology: General principles and mechanisms derived from animal studies","volume":"1","author":"Wilson","year":"1977"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/tera.1420510107","article-title":"Teratogenic potential of corticosteroids in humans","volume":"51","author":"Fraser","year":"1995","journal-title":"Teratology"},{"issue":"6","key":"10.1016\/j.bpobgyn.2014.07.020_bib16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib17","first-page":"1083","article-title":"Using corticosteroids during pregnancy: are topical, inhaled, or systemic agents associated with risk?","volume":"50","author":"Oren","year":"2004","journal-title":"Canadian Fam Physician"},{"issue":"7","key":"10.1016\/j.bpobgyn.2014.07.020_bib18","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib19","first-page":"117","article-title":"Immunosuppressives in pregnant transplant patients-what risks?","volume":"30","author":"Yeast","year":"1987","journal-title":"Pharmacology"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib20","series-title":"Drugs in Pregnancy and Lactation","first-page":"153","article-title":"Azathioprine","author":"Briggs","year":"2008"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib21","series-title":"The effects of drugs on the fetus and nursing infant: a handbook for health care professionals","author":"Friedman","year":"1996"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00007890-197901000-00007","article-title":"Pregnancy in renal transplant patients","volume":"27","author":"Rudolph","year":"1979","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0272-6386(12)81116-4","article-title":"Dialysis, transplantation, and pregnancy","volume":"17","author":"Davison","year":"1991","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib24","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/00007890-199402270-00004","article-title":"National transplantation pregnancy registry \u2013 outcomes of 154 pregnancies in cyclosporine-treated female kidney transplant recipients","volume":"57","author":"Armenti","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/bdra.20583","article-title":"Early pregnancy azathioprine use and pregnancy outcomes","volume":"85","author":"Cleary","year":"2009","journal-title":"Birth Defects Research (Part A): Clinical and Molecular Teratology"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib26","series-title":"A\u00a0clinicians guide to donation and transplantation","first-page":"613","article-title":"Pharmaceutical Care","author":"Gabardi","year":"2006"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib27","first-page":"9","article-title":"Cyclosporine-induced feto-toxicity in the rat","volume":"39","author":"Mason","year":"1985","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib28","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000243118","article-title":"Cyclosporin-induced embryotoxicity in mice","volume":"56","author":"Fein","year":"1989","journal-title":"Biol Neonate"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1136\/bmj.296.6625.825","article-title":"Pregnancy after renal transplantation: severe intra-uterine growth retardation during treatment with cyclosporin A","volume":"296","author":"Pickrell","year":"1988","journal-title":"BM J"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.07.020_bib30","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-013-0034-x","article-title":"Ciclosporin use during pregnancy","volume":"36","author":"Paziana","year":"2013","journal-title":"Drug Safety"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib31","series-title":"Drugs in pregnancy and lactation","first-page":"450","article-title":"Cyclosporine","author":"Briggs","year":"2008"},{"issue":"8","key":"10.1016\/j.bpobgyn.2014.07.020_bib32","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-200104270-00006","article-title":"Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis","volume":"71","author":"Oz","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib33","series-title":"Clinical transplants 2001","first-page":"97","article-title":"Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation","author":"Armenti","year":"2002"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00007890-199107000-00022","article-title":"The effect of two new immunosuppressive agents FK506 and Didemnin B, in murine pregnancy","volume":"52","author":"Farley","year":"1991","journal-title":"Transplantation"},{"issue":"12","key":"10.1016\/j.bpobgyn.2014.07.020_bib35","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/00007890-200012270-00010","article-title":"Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus","volume":"70","author":"Kainz","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib36","first-page":"1693A","article-title":"Structural birth defects in the newborn of solid organ transplant recipients","volume":"S2","author":"Sifontis","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00007890-199508000-00003","article-title":"Mycophenolate mofetil for the prevention of acute rejection in primary cadaver renal allograft recipients","volume":"60","author":"Sollinger","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib38","series-title":"Mycophenolate mofetil package insert","year":"2013"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib39","series-title":"Mycophenolic acid package insert","year":"2013"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib40","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.07.020_bib41","first-page":"335","article-title":"Parenthood with exposure to mycophenolic acid products","volume":"94","author":"Termini","year":"2012","journal-title":"Birth Defects Research (Part A)"},{"issue":"2","key":"10.1016\/j.bpobgyn.2014.07.020_bib42","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7182\/pit2013636","article-title":"Outcomes of pregnancies fathered by solid-organ transplant recipients exposed to mycophenolic acid products","volume":"23","author":"Jones","year":"2013","journal-title":"Prog Transplant"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib43","series-title":"Sirolimus package insert","year":"2012"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib44","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.transproceed.2004.11.102","article-title":"Absence of teratogenicity of sirolimus used during early pregnancy","volume":"36","author":"Jankowska","year":"2004","journal-title":"Transplant Proc"},{"issue":"91(9)","key":"10.1016\/j.bpobgyn.2014.07.020_bib45","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1097\/TP.0b013e3182154267","article-title":"Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation","volume":"15","author":"Framarino dei Malatesta","year":"2011","journal-title":"Transplantation"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.07.020_bib46","first-page":"161","article-title":"Pregnancy Outcomes in Solid Organ Transplant Recipients with Exposure to Sirolimus","volume":"13","author":"Constantinescu","year":"2013","journal-title":"Am J Transplant"},{"issue":"4","key":"10.1016\/j.bpobgyn.2014.07.020_bib47","doi-asserted-by":"crossref","first-page":"52","DOI":"10.12659\/AOT.883694","article-title":"Safety and efficacy of everolimus after kidney and hematopoietic stem cell transplantation","volume":"17","author":"Keller","year":"2012","journal-title":"Ann Transplant"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib48","series-title":"Everolimus package insert","year":"2013"},{"issue":"12","key":"10.1016\/j.bpobgyn.2014.07.020_bib49","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1111\/j.1432-2277.2011.01356.x","article-title":"Pregnancy under everolimus-based immunosuppression","volume":"24","author":"Veroux","year":"2011","journal-title":"Transpl Int"},{"issue":"2","key":"10.1016\/j.bpobgyn.2014.07.020_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1053\/j.ajkd.2012.05.012","article-title":"Pregnancy in a kidney transplant patient treated with everolimus","volume":"60","author":"Carta","year":"2012","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.bpobgyn.2014.07.020_bib51","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1111\/ctr.12044","article-title":"The role of belatacept in transplantation: results and implications of clinical trials in the context of other new biological immunosuppressant agents","volume":"27","author":"Heeman","year":"2013","journal-title":"Clin Transplant"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib52","first-page":"385","article-title":"Belatacept for prevention of acute rejection in adult patients who have had a kidney transplant: an update","volume":"6","author":"Wojciechowski","year":"2012","journal-title":"Biologics: Target and Therapy"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib53","series-title":"Belatacept package insert","year":"2013"},{"issue":"16","key":"10.1016\/j.bpobgyn.2014.07.020_bib54","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.2165\/00003495-200262160-00004","article-title":"Immunosuppression in pregnancy. Choices for infant and maternal health","volume":"62","author":"Armenti","year":"2002","journal-title":"Drugs"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib55","series-title":"Basiliximab package insert","year":"2005"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib56","series-title":"Alemtuzumab package insert","year":"2009"},{"issue":"3","key":"10.1016\/j.bpobgyn.2014.07.020_bib57","first-page":"318","article-title":"Pregnancy following kidney homotransplantation from a non-twin. Report of a case with concurrent administration of azathioprine and prednisone","volume":"29","author":"Board","year":"1967","journal-title":"Obstet & Gynecol"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/oxfordjournals.ndt.a092129","article-title":"Successful pregnancies in woman on renal replacement therapy: report from the EDTA registry","volume":"7","author":"Rizzoni","year":"1992","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"10.1016\/j.bpobgyn.2014.07.020_bib59","first-page":"161","article-title":"Pregnancy outcomes in solid organ transplant recipients with a switch from a mycophenolic acid product to azathioprine prior to conception","volume":"13","author":"Sifontis","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib60","series-title":"2011 Annual report","author":"National Transplantation Pregnancy Registry (NTPR)","year":"2012"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib61","first-page":"861A","article-title":"Pregnancy outcomes in kidney recipients who discontinued mycophenolic acid products prior to conception","volume":"24S","author":"Constantinescu","year":"2013","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib62","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0041-1345(98)01519-X","article-title":"Developmental well-being in offspring of women receiving cyclosporine post-renal transplant","volume":"31","author":"Stanley","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.bpobgyn.2014.07.020_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.trre.2008.05.001","article-title":"Pregnancy after transplantation","volume":"22","author":"Armenti","year":"2008","journal-title":"Transplantation Reviews"},{"issue":"2","key":"10.1016\/j.bpobgyn.2014.07.020_bib64","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/11316280-000000000-00000","article-title":"Long-term neurodevelopment of children exposed in utero to ciclosporin after maternal renal transplant","volume":"12","author":"Nulman","year":"2010","journal-title":"Pediatr Drugs"},{"issue":"6","key":"10.1016\/j.bpobgyn.2014.07.020_bib65","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/TP.0b013e31827f84db","article-title":"Study of the ophthalmic system of babies delivered to transplant recipients","volume":"27;95","author":"Kociszewska-Najman","year":"2013","journal-title":"Transplantation"},{"issue":"4","key":"10.1016\/j.bpobgyn.2014.07.020_bib66","doi-asserted-by":"crossref","first-page":"113","DOI":"10.12659\/AOT.883701","article-title":"Ultrasonography of the brain, abdomen, and heart in neonates born to liver or renal transplant recipient mothers","volume":"17","author":"Kociszewska-Najman","year":"2012","journal-title":"Ann Transplant"}],"container-title":["Best Practice &amp; Research Clinical Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693414001448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T17:27:26Z","timestamp":1565717246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693414001448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":66,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1521693414001448"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.07.020","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppressive drugs and fetal outcome","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Obstetrics & Gynaecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2014.07.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}